BNR · Burning Rock Biotech Ltd
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on May 15, 2024; bars on opposite sides are not compared.
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BNR
this stock
Burning Rock Biotech Ltd
|
$93.12M | -54.8% | +9.2% | — | 0.4% |
|
TMO
Thermo Fisher Scientific Inc.
|
$217.52B | +1.0% | +14.5% | 31.7 | 1.3% |
|
DHR
Danaher Corp /De/
|
$141.79B | -11.5% | +8.5% | 35.8 | 1.7% |
|
NTRA
Natera, Inc.
|
$44.67B | +37.1% | -2.8% | — | 3.0% |
|
IDXX
Idexx Laboratories Inc /De
|
$43.02B | -19.3% | +10.4% | 38.4 | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on May 15, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BNR | -16.2% | -8.7% | -68.4% | +2.3% | -54.8% |
| SPY | -0.1% | +4.1% | +12.4% | +3.4% | +13.3% |
| vs SPY | -16.1% | -12.9% | -80.8% | -1.2% | -68.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.